The $34.1 billion blockbuster deal between Aetna Inc. and Humana Inc. is seen as complementary to both health insurers in terms of helping grow their involvement in private and public health insurance exchanges.
Tucker Sharp, global chief broking officer with Aon Health, points out the two carriers participate in a number of different private exchanges, including Aons own fully insured HIX. While Aetna serves actives and retirees, Humana is primarily focused on the latter. The merger would not alter any of Aetnas strategy around participation in exchanges theyre going to be a big player in both active and retiree exchanges, he says.
Humanas involvement in the retiree exchange and innovation in the Medicare Advantage space is likely to deepen Aetnas breadth of offerings on the retiree exchange, according to Sharp. He says its doubtful the merger will have much impact on Aetnas participation in the active exchange because, again, Humanas commercial business that would play into that active exchange isnt that deep.
Since individual retail policies are among the fastest growing lines of business for many health insurers, then its possible that Aetna will be able to grow this area through its participation in public exchanges, observes Ed Kaplan, national health practice leader at The Segal Group. That scenario could dovetail right into Humanas individual Medicare product, he adds.
The merger wouldnt have too much impact on large employers because its more about the Medicare Advantage space than the commercial space at this point, according to Brian Marcotte, president and CEO of the National Business Group on Health. He says post-65 retiree options for accessing Medicare coverage isnt a market employers are as focused on as they were 10 years ago.
The timing of this proposed merger suggests a crucial timetable in the months ahead. Aetna CEO Mark Bertolini hopes antitrust regulators will approve the deal before they take an equally close look at a merger sought between Anthem and Cigna.
Another motivation is that his company would owe Humana a hefty $1 billion breakup fee based on 3.75% of the deals enterprise value if the proposal is blocked on antitrust grounds, according to The Wall Street Journal.
Bertolini and Humana CEO Bruce Broussard have expressed confidence that federal regulators will green-light the merger because the commercial coverage Aetna sells mainly to employers would complement Humanas strong Medicare presence.
Additional reporting by Andrea Davis
Register or login for access to this item and much more
All Employee Benefit Adviser content is archived after seven days.
Community members receive:
- All recent and archived articles
- Conference offers and updates
- A full menu of enewsletter options
- Web seminars, white papers, ebooks
Already have an account? Log In
Don't have an account? Register for Free Unlimited Access